Atlas

Form 483

Merck Sharp & Dohme LLC Form 483, 2019-06-28

FDA issued a Form 483 to Merck Sharp & Dohme LLC on 2019-06-28 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Merck Sharp & Dohme LLC · Elkton, United States · Issued June 28, 2019

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Jun 2019
21 CFR 211.192

Investigations of discrepancies, failures

Cited by David A Oluwo

28 Jun 2019
21 CFR 211.42(d)

Penicillin processing area not kept separate

Cited by David A Oluwo

Inspected site

MSMerck Sharp & Dohme LLCElkton, United States

Inspection team

DADavid A Oluwo

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.42(d)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere